Back to mobile site

Ideaya Biosciences (IDYA) Reiterated at Overweight by Cantor Fitzgerald

October 6, 2026 7:40 AM EDT Send to a Friend
Cantor Fitzgerald analyst Li Watsek reiterated an Overweight rating on Ideaya Biosciences (NASDAQ: IDYA).The analyst commented, "IDEAYA will have meaningful ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login